Stock Events

Stock Events

4 SC 

0
0
+€0.00+0% 00:00 Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Financials

-258.04%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
2.63MRevenue
-6.78MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Merck
MRK
Mkt Cap356.01B
Merck & Co., Inc. is a global healthcare company that operates in the pharmaceutical sector, directly competing with 4SC in the development and marketing of cancer treatments and therapies.
Bristol-Myers Squibb
BMY
Mkt Cap124.91B
Bristol-Myers Squibb Company is involved in the discovery, development, and delivery of medicines related to cancer, competing with 4SC in the oncology segment.
Pfizer
PFE
Mkt Cap158.45B
Pfizer Inc. is a research-based global biopharmaceutical company with a strong emphasis on oncology, making it a direct competitor to 4SC in cancer research and drug development.
Novartis
NVS
Mkt Cap268B
Novartis AG focuses on patented medicines, including those for cancer treatment, positioning it as a competitor to 4SC in the oncology pharmaceuticals market.
Roche
RHHBY
Mkt Cap334.28B
Roche Holding AG specializes in biotechnology and pharmaceuticals, with a significant portion of its portfolio dedicated to oncology, competing with 4SC in cancer treatment innovations.
Astrazeneca
AZN
Mkt Cap243.34B
AstraZeneca PLC is a multinational pharmaceutical and biopharmaceutical company with a strong focus on oncology, making it a competitor to 4SC in the development of cancer therapies.
Gilead Sciences
GILD
Mkt Cap179.47B
Gilead Sciences, Inc. is a biopharmaceutical company that develops and markets medicines in areas including oncology, competing with 4SC in the cancer treatment market.
AMGEN
AMGN
Mkt Cap217.9B
Amgen Inc. is a biotechnology company focused on human therapeutics, with a significant presence in oncology, competing with 4SC in the development of cancer treatments.
Johnson & Johnson
JNJ
Mkt Cap617.01B
Johnson & Johnson is a diversified healthcare company with pharmaceutical products targeting various diseases, including cancer, making it a competitor to 4SC in the oncology market.
Regeneron Pharmaceuticals
REGN
Mkt Cap75.69B
Regeneron Pharmaceuticals, Inc. is a biotechnology company that discovers, invents, develops, manufactures, and commercializes medicines for treating serious medical conditions, including cancer, positioning it as a competitor to 4SC in the field of oncology.

About

There is no Profile data available for VSC.SG.
Show More
CEO
Country
Germany
ISIN
DE000A14KL72
WKN
000A3E5C4

Listings

STU
DE
VSC.STU
STU
DE
VSC1.STU

0 Comments

Share your thoughts

FAQs

What is 4 SC stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Stuttgart exchange 4 SC stocks are traded under the ticker VSC1.STU.
What is 4 SC revenue for the last year?▼
4 SC revenue for the last year amounts to 2.63M EUR.
What is 4 SC net income for the last year?▼
VSC1.STU net income for the last year is -6.78M EUR.
In which sector is 4 SC located?▼
4 SC operates in the Materials sector.
When did 4 SC complete a stock split?▼
4 SC has not had any recent stock splits.